| Pfizer AG - Farlutal, Tabletten |
| 44307 | | 04 | | Farlutal | | Tabletten | | L02AB02 | | Medroxyprogesterone | | 21.11.1983 | | |
|
| Composition |
| medroxyprogesteroni acetas 500 mg, lactosum monohydricum 212.5 mg, crospovidonum, povidonum K 25, polysorbatum 80, cellulosum microcristallinum, magnesii stearas, pro compresso. |
| Packungsbestandteile |
| Tablets | | | | | Active Agent | Dose |
|---|
| Medroxyprogesterone Acetate | 500 mg |
| | BAG: Active Agent | Dose |
|---|
| Medroxyprogesterone Acetate | 500 mg |
| | | | Inactive agents | Dose |
|---|
| Cellulosum Microcristallinum | | | Crospovidonum | | | Lactose Monohydrate | 212.5 mg | | Magnesii Stearas | | | Polysorbatum 80 | | | Povidonum K | 25 | | Pro Compresso | |
| |
|
| Teilbarkeit |
| | Ja | | | | Ja | | | | Ja | | | | -- | | | | Alternative: Trinkampullen verwenden | | | | | |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 065 | 60 Tablet(s) | 115.08 | 141.55 | B | SL | Yes |
|
